XML 83 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation Plans
12 Months Ended
Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation Plans

7. Stock-Based Compensation Plans.

 

The Company has two Stock Option Plans (the 2000 Stock Option Plan and the 2006 Stock Option Plan) under which options for shares of common stock were granted to directors, officers and key employees. The 2006 plan permits the grant of stock options, stock appreciation rights, restricted stock awards, restricted stock units, or stock awards. The options awarded under the plans have similar characteristics. All stock options are non-qualified and expire ten years from the date of grant. Stock based compensation awarded to directors, officers and employees are exercisable immediately or become exercisable in cumulative installments of 20% or 25% at the end of each year following the date of grant. When stock options are exercised the Company issues new shares after receipt of exercise proceeds and taxes due, if any, from the grantee. The number of common shares available for future issuance was 486,590 at September 30, 2014.

 

The Company utilizes the Black-Scholes valuation model for estimating fair value of stock compensation for options awarded to officers and employees. Each grant is evaluated based upon assumptions at the time of grant. The assumptions were no dividend yield, expected volatility between 37% and 46%, risk-free interest rate of .3% to 4.2% and expected life of 3.0 to 7.0 years.

 

The dividend yield of zero is based on the fact that the Company does not pay cash dividends and has no present intention to pay cash dividends. Expected volatility is estimated based on the Company’s historical experience over a period equivalent to the expected life in years. The risk-free interest rate is based on the U.S. Treasury constant maturity interest rate at the date of grant with a term consistent with the expected life of the options granted. The expected life calculation is based on the observed and expected time to exercise options by the employees.

 

The Company recorded the following stock compensation expense in its consolidated statement of income (in thousands):

 

    Years Ended September 30
    2014   2013   2012
Stock option grants   $ 441       376       381  
Annual non-employee Director stock award     698       507       320  
    $ 1,139       883       701  

 

A summary of changes in outstanding options is presented below:

 

      Weighted   Weighted   Weighted
  Number   Average   Average   Average
  of   Exercise   Remaining   Grant Date
Options Shares   Price   Term (yrs)   Fair Value(000's)
               
Outstanding at                              
  October 1, 2011   606,025     $ 14.96       3.5     $ 4,216  
    Granted   31,690     $ 22.25             $ 281  
    Exercised   (153,505 )   $ 8.62             $ (705
    Forfeited   (3,000 )   $ 5.78             $ (10
Outstanding at                              
  September 30, 2012   481,210     $ 17.52       3.8     $ 3,782  
    Granted   46,180     $ 26.20             $ 489  
    Exercised   (112,800 )   $ 10.52             $ (603
    Forfeited   —       $ —               $ —    
Outstanding at                              
  September 30, 2013   414,590     $ 20.40       4.2     $ 3,668  
    Granted   31,790     $ 41.39             $ 545  
    Exercised   (119,550 )   $ 12.23             $ (732
    Forfeited   —       $ —               $ —    
Outstanding at                              
  September 30, 2014   326,830     $ 25.43       5.0     $ 3,481  
Exercisable at                              
  September 30, 2014   244,476     $ 23.82       4.0     $ 2,398  
Vested during                              
  twelve months ended                              
  September 30, 2014   33,148                     $ 372  

 

The following table summarizes information concerning stock options outstanding at September 30, 2014:

 

        Shares      Weighted     Weighted  
Range of Exercise       under     Average     Average  
Prices per Share       Option     Exercise Price   Remaining Life
                             
Non-exercisable:                            
$16.51 – $24.75       14,514         22.25       7.2  
$24.76 - $37.25       43,550         26.62       7.5  
$37.26 - $41.39       24,290         41.39       9.2  
        82,354       $ 30.21       8.0  years
Exercisable:                            
$11.00 - $16.50       55,800         14.92       0.4  
$16.51 - $24.75       68,176         22.57       4.1  
$24.76 - $37.25       113,000         27.79       5.3  
$37.26 - $41.39       7,500         41.39       9.2  
        244,476       $ 23.82       4.0  years
Total       326,830       $ 25.43       5.0  years

 

The aggregate intrinsic value of exercisable in-the-money options was $2,526,000 and the aggregate intrinsic value of outstanding in-the-money options was $3,014,000 based on the market closing price of $33.92 on September 30, 2014 less exercise prices. Gains of $2,918,000 were realized by option holders during the twelve months ended September 30, 2014. The realized tax benefit from options exercised for the twelve months ended September 30, 2014 was $1,129,000. Total compensation cost of options granted but not yet vested as of September 30, 2014 was $814,000, which is expected to be recognized over a weighted-average period of 3.3 years.